Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
China
· Delayed Price · Currency is CNY 13.14
-0.07 (-0.53%)
Apr 30, 2026, 9:55 AM CST
SHE:300401 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 7,182 | 8,217 | 7,967 | 6,486 | 7,929 | 7,813 | Upgrade
|
| Market Cap Growth | -6.14% | 3.14% | 22.84% | -18.20% | 1.48% | -9.56% | Upgrade
|
| Enterprise Value | 7,277 | 8,453 | 8,285 | 6,437 | 7,902 | 6,922 | Upgrade
|
| Last Close Price | 13.21 | 15.12 | 14.55 | 11.65 | 14.04 | 13.83 | Upgrade
|
| PE Ratio | 30.82 | 26.95 | 25.77 | 33.72 | 20.66 | 16.15 | Upgrade
|
| Forward PE | 16.51 | 6.18 | 6.18 | 6.18 | 6.18 | 6.18 | Upgrade
|
| PS Ratio | 6.05 | 6.64 | 6.41 | 5.93 | 5.59 | 6.99 | Upgrade
|
| PB Ratio | 2.03 | 2.36 | 2.48 | 2.24 | 3.08 | 3.42 | Upgrade
|
| P/TBV Ratio | 2.16 | 2.51 | 2.63 | 2.38 | 3.30 | 3.69 | Upgrade
|
| P/FCF Ratio | 36.44 | 72.86 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 13.54 | 17.31 | 17.08 | 40.54 | 21.03 | 15.25 | Upgrade
|
| EV/Sales Ratio | 6.13 | 6.83 | 6.66 | 5.88 | 5.58 | 6.20 | Upgrade
|
| EV/EBITDA Ratio | 14.49 | 15.69 | 17.57 | 21.26 | 17.24 | 14.12 | Upgrade
|
| EV/EBIT Ratio | 22.86 | 23.44 | 26.23 | 37.98 | 19.88 | 15.53 | Upgrade
|
| EV/FCF Ratio | 36.93 | 74.95 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.49 | 0.50 | 0.53 | 0.55 | 0.21 | 0.18 | Upgrade
|
| Debt / EBITDA Ratio | 3.45 | 3.25 | 3.64 | 5.24 | 1.16 | 0.85 | Upgrade
|
| Debt / FCF Ratio | 8.80 | 15.51 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.03 | 0.12 | 0.09 | 0.03 | -0.01 | -0.04 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.19 | 0.77 | 0.62 | 0.28 | -0.05 | -0.18 | Upgrade
|
| Net Debt / FCF Ratio | 0.48 | 3.69 | -20.79 | -0.99 | 7.80 | 0.43 | Upgrade
|
| Asset Turnover | 0.21 | 0.22 | 0.23 | 0.23 | 0.37 | 0.32 | Upgrade
|
| Inventory Turnover | 0.72 | 0.70 | 0.64 | 0.67 | 1.00 | 0.94 | Upgrade
|
| Quick Ratio | 1.43 | 1.65 | 1.24 | 1.26 | 0.55 | 0.66 | Upgrade
|
| Current Ratio | 2.08 | 2.52 | 1.94 | 1.95 | 1.06 | 1.24 | Upgrade
|
| Return on Equity (ROE) | 7.51% | 9.09% | 10.12% | 7.04% | 15.81% | 19.91% | Upgrade
|
| Return on Assets (ROA) | 3.45% | 3.96% | 3.63% | 2.26% | 6.49% | 7.85% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.33% | 8.41% | 8.40% | 5.59% | 14.53% | 19.66% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.70% | 7.50% | 7.30% | 4.20% | 14.10% | 16.90% | Upgrade
|
| Earnings Yield | 3.60% | 3.71% | 3.88% | 2.97% | 4.84% | 6.19% | Upgrade
|
| FCF Yield | 2.74% | 1.37% | -0.18% | -1.30% | -0.04% | -2.60% | Upgrade
|
| Dividend Yield | 0.86% | 0.75% | 0.78% | 0.61% | 1.00% | 1.36% | Upgrade
|
| Payout Ratio | 37.88% | 30.23% | 21.80% | 53.59% | 31.99% | 13.64% | Upgrade
|
| Buyback Yield / Dilution | -4.71% | -0.53% | 1.07% | -9.65% | -0.85% | -7.38% | Upgrade
|
| Total Shareholder Return | -3.85% | 0.22% | 1.86% | -9.04% | 0.15% | -6.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.